
                                                                                                             
                                                                                                                                                                                                                                                                                                                                       
                                                                                                             <?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Arthritis Remedies &#187; inducing</title>
	<atom:link href="http://www.remediesarthritis.com/tag/inducing/feed" rel="self" type="application/rss+xml" />
	<link>http://www.remediesarthritis.com</link>
	<description>All About Arthritis And Arthritis Treatment</description>
	<lastBuildDate>Wed, 08 Sep 2010 05:46:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Adeona Announces Publication of Results of 160 Patient Phase 2 Clinical Trial of Oral dnaJP1 for Rheumatoid Arthritis (Marketwire)</title>
		<link>http://www.remediesarthritis.com/adeona-announces-publication-of-results-of-160-patient-phase-2-clinical-trial-of-oral-dnajp1-for-rheumatoid-arthritis-marketwire.html</link>
		<comments>http://www.remediesarthritis.com/adeona-announces-publication-of-results-of-160-patient-phase-2-clinical-trial-of-oral-dnajp1-for-rheumatoid-arthritis-marketwire.html#comments</comments>
		<pubDate>Mon, 16 Nov 2009 09:30:06 +0000</pubDate>
		<dc:creator>Arthritis Expert</dc:creator>
				<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Causes Of Arthritis]]></category>
		<category><![CDATA[Osteoarthritis]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[adeona]]></category>
		<category><![CDATA[inducing]]></category>
		<category><![CDATA[partners]]></category>
		<category><![CDATA[peptide]]></category>
		<category><![CDATA[peptide-capable]]></category>
		<category><![CDATA[program]]></category>
		<category><![CDATA[published]]></category>
		<category><![CDATA[results-published]]></category>
		<category><![CDATA[Rheumatism]]></category>
		<category><![CDATA[seeking]]></category>
		<category><![CDATA[seeking-corporate]]></category>

		<guid isPermaLink="false">http://www.remediesarthritis.com/adeona-announces-publication-of-results-of-160-patient-phase-2-clinical-trial-of-oral-dnajp1-for-rheumatoid-arthritis-marketwire.html</guid>
		<description><![CDATA[Results Published in Journal, Arthritis &#038; Rheumatism; Oral Peptide Capable of Inducing Immune Tolerance to Key Antigen Expressed by 75% of RA Patients; Adeona Actively Seeking Corporate Partners for This Program]]></description>
			<content:encoded><![CDATA[<p class="dropcap-first">Results Published in Journal, Arthritis &#038; Rheumatism; Oral Peptide Capable of Inducing Immune Tolerance to Key Antigen Expressed by 75% of RA Patients; Adeona Actively Seeking Corporate Partners for This Program &#8230;</p>
<p><span id="more-352"></span></p>
<p>See the article here:<br />
<a target="_blank" href="http://us.rd.yahoo.com/dailynews/rss/search/Arthritis Treatment/SIG=12332fioc/*http://www.marketwire.com/mw/release.do?id=1076241&amp;sourceType=3" title="Adeona Announces Publication of Results of 160 Patient Phase 2 Clinical Trial of Oral dnaJP1 for Rheumatoid Arthritis (Marketwire)">Adeona Announces Publication of Results of 160 Patient Phase 2 Clinical Trial of Oral dnaJP1 for Rheumatoid Arthritis (Marketwire)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.remediesarthritis.com/adeona-announces-publication-of-results-of-160-patient-phase-2-clinical-trial-of-oral-dnajp1-for-rheumatoid-arthritis-marketwire.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
                                                                                                             
                                                                                                             